Investing Profile

Ted Xutian Jing

InvestorVC
Managing Director at 5Y Capital
Photo of Ted Xutian Jing, Managing Director at 5Y Capital
cb
5Y Capital Managing Director
$100K - $5.0M
$1.5M
6
$5B
CompanyStageDateRound SizeTotal Raised
ReviR Therapeutics
Series AJul 2024$30M
SeedJan 2022$20M
$50M
Regenerative Bio
AngelFeb 2022$10M
$10M
Co-investors: Wei Guo (UpHonest Capital)
Abogen Biosciences
Series CNov 2021$300M
$300M
Zhongke Guosheng
AngelNov 2021$8M
$8M
Polaris Biology
Series AJan 2019$8M
$8M